Previous studies and systematic reviews showed that the variables associated with NASH and progressive fibrosis in patients with NAFLD were obesity (especially visceral obesity), increasing BMI, hypertension, T2DM, AST/ALT ratio > 1 and decreased PLT count29–31. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.